Immunological and inflammatory functions of the interleukin-1 family.
暂无分享,去创建一个
[1] P. Tak,et al. Pharmacokinetics of IL-18 binding protein in healthy volunteers and subjects with rheumatoid arthritis or plaque psoriasis , 2006, European Journal of Drug Metabolism and Pharmacokinetics.
[2] P. Halban,et al. Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation. , 2008, The Journal of clinical endocrinology and metabolism.
[3] D. Mann,et al. Cutting Edge: IL-1 Controls the IL-23 Response Induced by Gliadin, the Etiologic Agent in Celiac Disease1 , 2008, The Journal of Immunology.
[4] C. Dinarello,et al. 120 The IL-1 family member IL-1F7 reduces innate immunity by inhibiting Toll-like receptor and IL-1 signaling pathways , 2008 .
[5] L. Punzi,et al. Resistant Behçet disease responsive to anakinra. , 2008, Annals of internal medicine.
[6] G. Yancopoulos,et al. Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies. , 2008, Arthritis and rheumatism.
[7] Andrew G. Watts,et al. A Key Role for Redox Signaling in Rapid P2X7 Receptor-Induced IL-1β Processing in Human Monocytes1 , 2008, The Journal of Immunology.
[8] G. Fantuzzi,et al. Interleukin-18, together with interleukin-12, induces severe acute pancreatitis in obese but not in nonobese leptin-deficient mice , 2008, Proceedings of the National Academy of Sciences.
[9] M. Lynch,et al. IL‐1F5 mediates anti‐inflammatory activity in the brain through induction of IL‐4 following interaction with SIGIRR/TIR8 , 2008, Journal of neurochemistry.
[10] A. Pshezhetsky,et al. Development of a Novel Noncompetitive Antagonist of IL-1 Receptor1 , 2008, The Journal of Immunology.
[11] Sheetal Sharma,et al. The IL-1 Family Member 7b Translocates to the Nucleus and Down-Regulates Proinflammatory Cytokines1 , 2008, The Journal of Immunology.
[12] Ashley M. Miller,et al. IL-33 reduces the development of atherosclerosis , 2008, The Journal of experimental medicine.
[13] K. Nakanishi,et al. Protective Effect of IL-18 on Kainate- and IL-1β-Induced Cerebellar Ataxia in Mice1 , 2008, The Journal of Immunology.
[14] J. O’Shea,et al. Th17 cells: a new fate for differentiating helper T cells , 2008, Immunologic research.
[15] B. Hassan,et al. A Comparative Study of Interleukin-1β Production and P2x7 Expression After Atp Stimulation by Peripheral Blood Mononuclear Cells Isolated From Rheumatoid Arthritis Patients and Normal Healthy Controls , 2008, Inflammation.
[16] M. Huber,et al. IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells , 2007, Proceedings of the National Academy of Sciences.
[17] Y. Sharabi,et al. Differential role and tissue specificity of interleukin-1alpha gene expression in atherogenesis and lipid metabolism. , 2007, Atherosclerosis.
[18] M. Neuenhahn,et al. NF-κB Is a Negative Regulator of IL-1β Secretion as Revealed by Genetic and Pharmacological Inhibition of IKKβ , 2007, Cell.
[19] A. Martini,et al. Pattern of interleukin-1beta secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations. , 2007, Arthritis and rheumatism.
[20] C. Dinarello. Mutations in cryopyrin: bypassing roadblocks in the caspase 1 inflammasome for interleukin-1beta secretion and disease activity. , 2007, Arthritis and rheumatism.
[21] R. Kastelein,et al. IL-1 Receptor Accessory Protein and ST2 Comprise the IL-33 Receptor Complex , 2007, The Journal of Immunology.
[22] F. Sallusto,et al. Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17–producing human T helper cells , 2007, Nature Immunology.
[23] G. Dubyak,et al. Nonclassical IL-1β Secretion Stimulated by P2X7 Receptors Is Dependent on Inflammasome Activation and Correlated with Exosome Release in Murine Macrophages1 , 2007, The Journal of Immunology.
[24] C. Sasakawa,et al. Differential Regulation of Caspase-1 Activation, Pyroptosis, and Autophagy via Ipaf and ASC in Shigella-Infected Macrophages , 2007, PLoS pathogens.
[25] T. Naka,et al. IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cells , 2007, Proceedings of the National Academy of Sciences.
[26] Junichi Tsukada,et al. Phosphorylation of IRF8 in a pre-associated complex with Spi-1/PU.1 and non-phosphorylated Stat1 is critical for LPS induction of the IL1B gene. , 2007, Molecular immunology.
[27] E. Zorrilla,et al. Interleukin-18 controls energy homeostasis by suppressing appetite and feed efficiency , 2007, Proceedings of the National Academy of Sciences.
[28] S. Akira,et al. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells , 2007, Nature Medicine.
[29] M. Gadina,et al. IL-33: A Sheep in Wolf’s Clothing? , 2007, Science's STKE.
[30] Richard T. Lee,et al. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. , 2007, The Journal of clinical investigation.
[31] S. Park,et al. P2X7 receptor polymorphism and clinical outcomes in HLA-matched sibling allogeneic hematopoietic stem cell transplantation. , 2007, Haematologica.
[32] P. Vandenabeele,et al. Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling. , 2007, Immunity.
[33] Allan Vaag,et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. , 2007, The New England journal of medicine.
[34] C. Dinarello,et al. Antiviral and immunoregulatory activities of IFN-γ depend on constitutively expressed IL-1α , 2007, Proceedings of the National Academy of Sciences.
[35] J. Tschopp,et al. A pilot study of IL-1 inhibition by anakinra in acute gout , 2007, Arthritis research & therapy.
[36] N. Rothwell,et al. Caspase-1-dependent processing of pro-interleukin-1β is cytosolic and precedes cell death , 2007, Journal of Cell Science.
[37] Yoichiro Iwakura,et al. Interleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors. , 2007, Cancer research.
[38] Delphine A. Lacorre,et al. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo , 2007, Proceedings of the National Academy of Sciences.
[39] F. Martinon,et al. Inflammatory caspases and inflammasomes: master switches of inflammation , 2007, Cell Death and Differentiation.
[40] J. Meer,et al. Physiology and Pharmacology of Temperature Regulation Pathogenesis of familial periodic fever syndromes or hereditary autoinflammatory syndromes , 2006 .
[41] C. Dinarello,et al. Responses of IL-18- and IL-18 receptor-deficient pancreatic islets with convergence of positive and negative signals for the IL-18 receptor , 2006, Proceedings of the National Academy of Sciences.
[42] A. Surprenant,et al. Pannexin‐1 mediates large pore formation and interleukin‐1β release by the ATP‐gated P2X7 receptor , 2006, The EMBO journal.
[43] D. Chang,et al. Adenovirus expressing interleukin-1 receptor antagonist alleviates allergic airway inflammation in a murine model of asthma , 2006, Gene Therapy.
[44] N. Kamatani,et al. Intracellular IL-1α-binding proteins contribute to biological functions of endogenous IL-1α in systemic sclerosis fibroblasts , 2006, Proceedings of the National Academy of Sciences.
[45] B. Becher,et al. Interleukin 18–independent engagement of interleukin 18 receptor-α is required for autoimmune inflammation , 2006, Nature Immunology.
[46] S. Holland,et al. Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. , 2006, The New England journal of medicine.
[47] K. Mills,et al. A crucial role for interleukin (IL)-1 in the induction of IL-17–producing T cells that mediate autoimmune encephalomyelitis , 2006, The Journal of experimental medicine.
[48] T. Yakovleva,et al. Characterization of Binding Properties of ICAM‐1 Peptides to LFA‐1: Inhibitors of T‐cell Adhesion , 2006, Chemical biology & drug design.
[49] L. Hazlett,et al. SIGIRR Promotes Resistance against Pseudomonas aeruginosa Keratitis by Down-Regulating Type-1 Immunity and IL-1R1 and TLR4 Signaling1 , 2006, The Journal of Immunology.
[50] W. Alexander,et al. SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritis. , 2006, The Journal of clinical investigation.
[51] Shizuo Akira,et al. Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance , 2006, Nature Medicine.
[52] C. Gabay,et al. The new IL-1 family member IL-1F8 stimulates production of inflammatory mediators by synovial fibroblasts and articular chondrocytes , 2006, Arthritis research & therapy.
[53] S. Nakae,et al. Abnormal T cell activation caused by the imbalance of the IL-1/IL-1R antagonist system is responsible for the development of experimental autoimmune encephalomyelitis. , 2006, International immunology.
[54] D. Boraschi,et al. The interleukin-1 receptor family. , 2006, Vitamins and hormones.
[55] J. Nerup,et al. Affinity-purified human Interleukin I is cytotoxic to isolated islets of Langerhans , 2006, Diabetologia.
[56] L. G. Volkert,et al. Gene expression profiling of microglia infected by a highly neurovirulent murine leukemia virus: implications for neuropathogenesis , 2006, Retrovirology.
[57] G. Dubyak,et al. Potentiation of Caspase-1 Activation by the P2X7 Receptor Is Dependent on TLR Signals and Requires NF-κB-Driven Protein Synthesis1 , 2005, The Journal of Immunology.
[58] C. Dinarello,et al. Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome. , 2005, Blood.
[59] J Fernando Bazan,et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. , 2005, Immunity.
[60] V. Johnson,et al. Prevention of IL-1 signaling attenuates airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma. , 2005, The Journal of allergy and clinical immunology.
[61] N. Rothwell,et al. A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[62] Xiaoxia Li,et al. SIGIRR Inhibits Interleukin-1 Receptor- and Toll-like Receptor 4-mediated Signaling through Different Mechanisms* , 2005, Journal of Biological Chemistry.
[63] C. Dinarello. The many worlds of reducing interleukin-1. , 2005, Arthritis and rheumatism.
[64] H. Carlsen,et al. Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist. , 2005, Arthritis and rheumatism.
[65] C. Dinarello,et al. Rapid responses to anakinra in patients with refractory adult-onset Still's disease. , 2005, Arthritis and rheumatism.
[66] V. Pascual,et al. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade , 2005, The Journal of experimental medicine.
[67] P. Anand,et al. Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain , 2005, Pain.
[68] R. Sluyter,et al. P2X7 receptor polymorphism impairs extracellular adenosine 5′-triphosphate-induced interleukin-18 release from human monocytes , 2004, Genes and Immunity.
[69] C. Dinarello. Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammation. , 2004, Current opinion in pharmacology.
[70] C. Dinarello,et al. Interleukin-1 homologues IL-1F7b and IL-18 contain functional mRNA instability elements within the coding region responsive to lipopolysaccharide. , 2004, The Biochemical journal.
[71] K. Beaman,et al. Regeneration and tolerance factor modulates the effect of adenosine triphosphate-induced interleukin 1 beta secretion in human macrophages. , 2004, Human immunology.
[72] J. Sturis,et al. Glucose- and interleukin-1beta-induced beta-cell apoptosis requires Ca2+ influx and extracellular signal-regulated kinase (ERK) 1/2 activation and is prevented by a sulfonylurea receptor 1/inwardly rectifying K+ channel 6.2 (SUR/Kir6.2) selective potassium channel opener in human islets. , 2004, Diabetes.
[73] I. McInnes,et al. A Novel Therapy of Murine Collagen-Induced Arthritis with Soluble T1/ST21 , 2004, The Journal of Immunology.
[74] M. Torrisi,et al. Phospholipases C and A2 control lysosome-mediated IL-1 beta secretion: Implications for inflammatory processes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[75] G. Dubyak,et al. Mechanisms of caspase-1 activation by P2X7 receptor-mediated K+ release. , 2004, American journal of physiology. Cell physiology.
[76] J. Sims,et al. Interleukin (IL)-1F6, IL-1F8, and IL-1F9 Signal through IL-1Rrp2 and IL-1RAcP to Activate the Pathway Leading to NF-κB and MAPKs* , 2004, Journal of Biological Chemistry.
[77] J. Wiley,et al. Glu496 to Ala Polymorphism in the P2X7 Receptor Impairs ATP-Induced IL-1β Release from Human Monocytes1 , 2004, The Journal of Immunology.
[78] C. Garlanda,et al. Intestinal inflammation in mice deficient in Tir8, an inhibitory member of the IL-1 receptor family. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[79] F. Martinon,et al. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. , 2004, Immunity.
[80] C. Dinarello,et al. The precursor form of IL-1alpha is an intracrine proinflammatory activator of transcription. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[81] D. Yoon,et al. Identification of a Critical Ig-Like Domain in IL-18 Receptor α and Characterization of a Functional IL-18 Receptor Complex 1 , 2003, The Journal of Immunology.
[82] G. Stark,et al. SIGIRR, a negative regulator of Toll-like receptor–interleukin 1 receptor signaling , 2003, Nature Immunology.
[83] M. Haniuda,et al. Serine protease inhibitors modulate chemotactic cytokine production by human lung fibroblasts in vitro. , 2003, American journal of physiology. Lung cellular and molecular physiology.
[84] S. Nakae,et al. IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[85] D. Kastner,et al. Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. , 2003, Molecular cell.
[86] Y. Iwakura,et al. IL-1 is required for tumor invasiveness and angiogenesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[87] Andrea Vondracek,et al. Mechanisms of Inhibition of Collagen-Induced Arthritis by Murine IL-18 Binding Protein 1 , 2003, The Journal of Immunology.
[88] M. Lotze,et al. Innate Immunity Mediated by the Cytokine IL-1 Homologue 4 (IL-1H4/IL-1F7) Induces IL-12-Dependent Adaptive and Profound Antitumor Immunity1 , 2003, The Journal of Immunology.
[89] Scott Carver,et al. Cytokine traps: multi-component, high-affinity blockers of cytokine action , 2003, Nature Medicine.
[90] K. Wilson,et al. Prointerleukin-16 contains a functional CcN motif that regulates nuclear localization. , 2002, Biochemistry.
[91] E. Remmers,et al. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. , 2002, Arthritis and rheumatism.
[92] C. Dinarello,et al. A complex of the IL-1 homologue IL-1F7b and IL-18-binding protein reduces IL-18 activity , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[93] G. Hitman,et al. Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. , 2002, Arthritis and rheumatism.
[94] S. Akira,et al. IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE/stat6 under specific pathogen-free conditions , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[95] S. Argov,et al. Different patterns of interleukin-1alpha and interleukin-1beta expression in organs of normal young and old mice. , 2002, European cytokine network.
[96] John C. Lee,et al. Interleukin-1F7B (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-gamma production. , 2002, Cytokine.
[97] D. Yoon,et al. Identification of Amino Acid Residues Critical for Biological Activity in Human Interleukin-18* , 2002, The Journal of Biological Chemistry.
[98] S. Nakae,et al. Interleukin‐1β, but not interleukin‐1α, is required for T‐cell‐dependent antibody production , 2001 .
[99] H. Okamura,et al. Neutrophil Proteinase 3-Mediated Induction of Bioactive IL-18 Secretion by Human Oral Epithelial Cells1 , 2001, The Journal of Immunology.
[100] P. Dawson,et al. Identification of a novel human cytokine gene in the interleukin gene cluster on chromosome 2q12-14. , 2001, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[101] R. Kolodner,et al. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle–Wells syndrome , 2001, Nature Genetics.
[102] B. Moss,et al. Correspondence of the Functional Epitopes of Poxvirus and Human Interleukin-18-Binding Proteins , 2001, Journal of Virology.
[103] R. Kastelein,et al. Two Novel IL-1 Family Members, IL-1δ and IL-1ε, Function as an Antagonist and Agonist of NF-κB Activation Through the Orphan IL-1 Receptor-Related Protein 21 , 2001, The Journal of Immunology.
[104] M. Vidal,et al. EVIDENCE THAT HAX-1 IS AN INTERLEUKIN-1α N-TERMINAL BINDING PROTEIN , 2001 .
[105] J. Miyazaki,et al. Cutting Edge: IL-18-Transgenic Mice: In Vivo Evidence of a Broad Role for IL-18 in Modulating Immune Function , 2001, The Journal of Immunology.
[106] J. E. Ford,et al. Cloning and Characterization of IL-1HY2, a Novel Interleukin-1 Family Member* , 2001, The Journal of Biological Chemistry.
[107] G. Fantuzzi,et al. A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18. , 2001, Cytokine.
[108] K. Tracey,et al. HMG‐1 REDISCOVERED AS A CYTOKINE , 2001, Shock.
[109] H. Okamura,et al. Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. , 2001, Cytokine & growth factor reviews.
[110] Beverly H. Koller,et al. Altered Cytokine Production in Mice Lacking P2X7Receptors* , 2001, The Journal of Biological Chemistry.
[111] H. Young,et al. Functional Reconstitution and Regulation of IL-18 Activity by the IL-18Rβ Chain1 , 2001, The Journal of Immunology.
[112] Phillip E. Risser,et al. IL-1H, an interleukin 1-related protein that binds IL-18 receptor/IL-1Rrp. , 2001, Cytokine.
[113] R. Herbst,et al. A tissue specific IL‐1 receptor antagonist homolog from the IL‐1 cluster lacks IL‐1, IL‐1ra, IL‐18 and IL‐18 antagonist activities , 2000, European journal of immunology.
[114] R. Kastelein,et al. Computational identification, cloning, and characterization of IL-1R9, a novel interleukin-1 receptor-like gene encoded over an unusually large interval of human chromosome Xq22.2-q22.3. , 2000, Genomics.
[115] C. Gabel,et al. ATP Acts as an Agonist to Promote Stimulus-Induced Secretion of IL-1β and IL-18 in Human Blood , 2000, The Journal of Immunology.
[116] D. Neumann,et al. The Membrane Form of the Type II IL-1 Receptor Accounts for Inhibitory Function1 , 2000, The Journal of Immunology.
[117] M. Zocchi,et al. Secretion of bioactive interleukin-1beta by dendritic cells is modulated by interaction with antigen specific T cells. , 2000, Blood.
[118] S. Busfield,et al. Identification and gene organization of three novel members of the IL-1 family on human chromosome 2. , 2000, Genomics.
[119] M. Kurimoto,et al. IFN-γ-Dependent and -Independent Mechanisms in Adverse Effects Caused by Concomitant Administration of IL-18 and IL-12 , 2000, The Journal of Immunology.
[120] G. Duff,et al. Arterial Inflammation in Mice Lacking the Interleukin 1 Receptor Antagonist Gene , 2000, The Journal of experimental medicine.
[121] S. Nakae,et al. Development of Chronic Inflammatory Arthropathy Resembling Rheumatoid Arthritis in Interleukin 1 Receptor Antagonist–Deficient Mice , 2000, The Journal of experimental medicine.
[122] I. McInnes,et al. A proinflammatory role for IL-18 in rheumatoid arthritis. , 1999, The Journal of clinical investigation.
[123] J. E. Ford,et al. IL1HY1: A novel interleukin-1 receptor antagonist gene. , 1999, Biochemical and biophysical research communications.
[124] G. Fantuzzi,et al. IL-12–induced IFN-γ is dependent on caspase-1 processing of the IL-18 precursor , 1999 .
[125] S. Akira,et al. Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice. , 1999, Immunity.
[126] Lin Jun,et al. A new member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation , 1999, Nature Genetics.
[127] C. Coeshott,et al. Converting enzyme-independent release of tumor necrosis factor alpha and IL-1beta from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[128] M. Torrisi,et al. The secretory route of the leaderless protein interleukin 1beta involves exocytosis of endolysosome-related vesicles. , 1999, Molecular biology of the cell.
[129] M. Netea,et al. Soluble murine IL-1 receptor type I induces release of constitutive IL-1 alpha. , 1999, Journal of immunology.
[130] G. Fantuzzi,et al. Gene expression, synthesis, and secretion of interleukin 18 and interleukin 1beta are differentially regulated in human blood mononuclear cells and mouse spleen cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[131] M. Pras,et al. MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever. , 1999, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[132] G. Fantuzzi,et al. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. , 1999, Immunity.
[133] K. McIntyre,et al. IL-1 receptor accessory protein is an essential component of the IL-1 receptor. , 1998, Journal of immunology.
[134] T. Born,et al. Cloning of a Novel Receptor Subunit, AcPL, Required for Interleukin-18 Signaling* , 1998, The Journal of Biological Chemistry.
[135] R. Klemenz,et al. The IL-1 receptor-related T1 antigen is expressed on immature and mature mast cells and on fetal blood mast cell progenitors. , 1998, Journal of immunology.
[136] T. Bártfai,et al. Interleukin‐1 receptor accessory protein interacts with the type II interleukin‐1 receptor , 1998, FEBS letters.
[137] Masatoshi Suzuki,et al. Production of Mice Deficient in Genes for Interleukin (IL)-1α, IL-1β, IL-1α/β, and IL-1 Receptor Antagonist Shows that IL-1β Is Crucial in Turpentine-induced Fever Development and Glucocorticoid Secretion , 1998, The Journal of experimental medicine.
[138] V. Fadok,et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. , 1998, The Journal of clinical investigation.
[139] G. Fantuzzi,et al. IL-1β mediates leptin induction during inflammation. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.
[140] K. Torigoe,et al. Purification and Characterization of the Human Interleukin-18 Receptor* , 1997, The Journal of Biological Chemistry.
[141] G. Fantuzzi,et al. Response to local inflammation of IL-1 beta-converting enzyme- deficient mice. , 1997, Journal of immunology.
[142] R. Locksley,et al. The N-terminal propiece of interleukin 1α is a transforming nuclear oncoprotein , 1997 .
[143] S. Paul,et al. Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[144] G. Fantuzzi,et al. Effect of endotoxin in IL-1 beta-deficient mice. , 1996, Journal of immunology.
[145] C. Dinarello,et al. Biologic basis for interleukin-1 in disease. , 1996, Blood.
[146] M. Gayle,et al. T1/ST2 Signaling Establishes It as a Member of an Expanding Interleukin-1 Receptor Family (*) , 1996, The Journal of Biological Chemistry.
[147] S. Dower,et al. IL-1Rrp Is a Novel Receptor-like Molecule Similar to the Type I Interleukin-1 Receptor and Its Homologues T1/ST2 and IL-1R AcP (*) , 1996, The Journal of Biological Chemistry.
[148] J. Sinacore,et al. Recombinant human interleukin-1 receptor type I in the treatment of patients with active rheumatoid arthritis. , 1996, Arthritis and rheumatism.
[149] H. Okamura,et al. Cloning of a new cytokine that induces IFN-γ production by T cells , 1995, Nature.
[150] A. Shaw,et al. Resistance to fever induction and impaired acute-phase response in interleukin-1 beta-deficient mice. , 1995, Immunity.
[151] M. Su,et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. , 1995, Science.
[152] C. Dinarello,et al. Cytokines in human renal interstitial fibrosis. II. Intrinsic interleukin (IL)-1 synthesis and IL-1-dependent production of IL-6 and IL-8 by cultured kidney fibroblasts. , 1995, Kidney international.
[153] P. Bongrand,et al. Interleukin-1 induces interleukin-8 secretion from endothelial cells by a juxtacrine mechanism. , 1994, Blood.
[154] A. Mantovani,et al. The type II 'decoy' receptor: a novel regulatory pathway for interleukin 1. , 1994, Immunology today.
[155] L. Gehrke,et al. Peripheral blood mononuclear cells stimulated with C5a or lipopolysaccharide to synthesize equivalent levels of IL-1 beta mRNA show unequal IL-1 beta protein accumulation but similar polyribosome profiles. , 1994, Journal of immunology.
[156] M. Busslinger,et al. Alternative promoter usage of the Fos‐responsive gene Fit‐1 generates mRNA isoforms coding for either secreted or membrane‐bound proteins related to the IL‐1 receptor. , 1994, The EMBO journal.
[157] J. Maier,et al. Endogenous interleukin 1 alpha must be transported to the nucleus to exert its activity in human endothelial cells , 1994, Molecular and cellular biology.
[158] A. Mantovani,et al. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. , 1993, Science.
[159] C. Dinarello,et al. Identification of the promoter region of human interleukin 1 type I receptor gene: multiple initiation sites, high G+C content, and constitutive expression. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[160] J. Voorhees,et al. Interleukin-1 receptor antagonist in normal and psoriatic epidermis. , 1992, The Journal of clinical investigation.
[161] C. Dinarello,et al. Dissociation between interleukin-1 beta mRNA and protein synthesis in human peripheral blood mononuclear cells. , 1990, The Journal of biological chemistry.
[162] P. Ghezzi,et al. IL-1 induces IL-1. IV. IFN-gamma suppresses IL-1 but not lipopolysaccharide-induced transcription of IL-1. , 1990, Journal of immunology.
[163] P. Libby,et al. Interleukin 1 induces interleukin 1. I. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro. , 1987, Journal of immunology.
[164] D. Boraschi,et al. A short synthetic peptide fragment of human interleukin 1 with immunostimulatory but not inflammatory activity. , 1986, Journal of immunology.
[165] J. Nerup,et al. Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. , 1986, Science.
[166] E. Unanue,et al. Identification of a membrane-associated interleukin 1 in macrophages. , 1985, Proceedings of the National Academy of Sciences of the United States of America.